Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens. | Mol Ther;1(3): 275-84, 2000 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens.

Perricone, M A; Claussen, K A; Smith, K A; Kaplan, J M; Piraino, S; Shankara, S; Roberts, B L.

Affiliation

Perricone MA; Genzyme Molecular Oncology, Framingham, Massachusetts 01701-9322, USA. michael.perricone@genzyme.com

Mol Ther ; 1(3): 275-84, 2000 Mar.

Article in En | MEDLINE | ID: mdl-10933943

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Genetic Therapy / Adenoviridae / Intramolecular Oxidoreductases / Melanoma / Antigens, Neoplasm / Neoplasm Proteins Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2000 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Membrane Glycoproteins / Genetic Therapy / Adenoviridae / Intramolecular Oxidoreductases / Melanoma / Antigens, Neoplasm / Neoplasm Proteins Type of study: Risk_factors_studies Limits: Animals / Humans Language: En Journal: Mol Ther Journal subject: BIOLOGIA MOLECULAR / TERAPEUTICA Year: 2000 Document type: Article Affiliation country: Country of publication: